Role of intraspinal analgesia in terminal pediatric malignancy

Journal of Clinical Oncology

Volumn 23, Issue 6, 2005, Pages 1318-1321

  Saroyan, J M ^a   Schechter, William S ^a   Tresgallo, M E ^a   Granowetter, L ^a  

^a College of Physicians and Surgeons at Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CARBOPLATIN; CELECOXIB; CLONIDINE; ETOPOSIDE; GABAPENTIN; HYDROMORPHONE; IFOSFAMIDE; METHADONE; MORPHINE; OXCARBAZEPINE; TOPOTECAN; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ANALGESIA; CASE REPORT; CHILDHOOD DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NODULE; OSTEOSARCOMA; PAIN; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; INDWELLING CATHETER; INTRACTABLE PAIN; PALLIATIVE THERAPY; SUBARACHNOID SPACE;

ADOLESCENT; ANALGESICS, OPIOID; CATHETERS, INDWELLING; FEMALE; HUMANS; MORPHINE; PAIN, INTRACTABLE; PALLIATIVE CARE; SUBARACHNOID SPACE;

EID: 14544284089     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.07.008     Document Type: Review

References (18)

1. Berde CB: Regional analgesia in the management of chronic pain in childhood. J Pain Symptom Manage 4:232-237, 1989
2. Collins JJ, Grier HE, Sethna NF, et al: Regional anesthesia for pain associated with terminal pediatric malignancy. Pain 65:63-69, 1996
3. Collins JJ, Grier HE, Kinney HC, et al: Control of severe pain in children with terminal malignancy. J Pediatr 126:653-657, 1995
4. Berde C, Ablin A, Glazer J, et al: Report of the subcommittee on disease related pain in childhood cancer. Pediatrics 86:818-825, 1990
5. Aram L, Krane EJ, Kozloski LJ, et al: Tunneled epidural catheters for prolonged analgesia in pediatric patients. Anesth Analg 92:1432-1438, 2001
6. Cooper MG, Keneally JP, Kinchington D: Continuous brachial plexus neural blockade in a child with intractable cancer pain. J Pain Symptom Manage 9:277-281, 1994
7. Hassenbusch SJ, Portenoy RK, Cousins M, et al: Consensus Conference 2003: An update on the management of pain by intraspinal drug delivery-Report of an expert panel. J Pain Symptom Manage 27:540-563, 2004
8. Krames ES: Intrathecal infusional therapies for intractable pain: Patient management guidelines. J Pain Symptom Manage 8:36-45, 1993
9. Eisenach JC, DuPen S, Dubois M, et al: The epidural clonidine study group epidural clonidine analgesia for intractable cancer pain. Pain 61:391-399, 1995
10. Samuelsson H, Nordberg G, Hedner T, et al: CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief. Pain 30:303-310, 1987
11. Horais K, Hruby V, Rossi S, et al: Effects of chronic intrathecal infusion of a delta opioid agonist in dogs. Toxicol Sci 71:263-275, 2003
12. Strafford MA, Wilder RT, Berde CB: The risk of infection from epidural analgesia in children: A review of 1620 cases. Anesth Analg 80:234-238, 1995
13. Sjoberg M, Nitescu P, Appelgren L, et al: Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain: Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml. Anesthesiology 80:284-297, 1994
14. Hassenbusch SJ, Paice JA, Patt RB, et al: Clinical realities and economic considerations: Economics of intrathecal therapy. J Pain Symptom Manage 14:S36-S47, 1997
15. Gestin Y, Vainio A, Pegurier AM: Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer. Acta Anaesthesiol Scand 41:12-17, 1997
16. Smith TJ, Staats PS, Deer T, et al: Randomized clinical trial of implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol 20:4040-4049, 2002
17. Wolfe J, Grier H, Klar N, et al: Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342:326-333, 2000
18. Page GG: The immune-suppressive effects of pain. Adv Exp Med Biol 521:117-125, 2003